1,3-Difluorobenzene

1,3-Difluorobenzene: Recent Market Intelligence Analysis

I. Market Price Dynamics
- Recent Quotations: According to data monitored by Shengyishe (Business Society), the benchmark price of 1,3-difluorobenzene remained stable on June 18 and June 22, 2026, with no significant fluctuations in transaction guidance prices. Regionally, the quotation in Jiangsu Province stood at RMB 50,000 per metric ton (99.5% purity), while that in Shandong Province was RMB 34,000 per metric ton (99.5% purity). This price divergence is primarily attributable to logistics costs, brand premium, and regional supply-demand dynamics.
- Historical Trend: From January to June 2026, the market average price of 1,3-difluorobenzene fluctuated within the range of RMB 34,000–36,800 per metric ton, exhibiting an overall trend of stability with a slight upward bias. Notably, from late April to early May, prices temporarily rose to RMB 38,666 per metric ton due to concentrated demand release from downstream pharmaceutical intermediates, before reverting to a rational range.

II. Supply-Demand Structure Analysis
- Supply Side:
- Production Capacity Distribution: Global 1,3-difluorobenzene production capacity is concentrated in China, the United States, Europe, and Japan, with China accounting for over 40%. Leading enterprises—including Zhejiang Xiehe New Materials Co., Ltd. and Fuxin Jinhongtai Chemical Co., Ltd.—have consolidated their market leadership through technological iteration and capacity expansion.
- Production Barriers: The fluorination reaction process imposes stringent requirements on equipment sealing integrity and temperature control precision. Moreover, environmental compliance investments—such as Regenerative Thermal Oxidizer (RTO) systems for exhaust gas treatment and advanced wastewater defluorination—account for 15–20% of total production costs, significantly constraining new entrants’ expansion pace.
- Demand Side:
- Core Application Areas: Pharmaceutical intermediates (representing 55% of total demand) and novel liquid crystal materials (25%) constitute the primary consumption sectors. Global pharmaceutical-sector demand for 1,3-difluorobenzene is projected to reach 42,000 metric tons in 2026, growing at an annual average rate of 6.8%, driven by expanding clinical pipelines of fluorinated anti-tumor drugs and increased generic drug market volume.
- Emerging Growth Drivers: Surging demand from solid-state battery electrolytes and high-performance polymer materials is expected to propel demand in this segment to 45,000 metric tons by 2030, representing a compound annual growth rate (CAGR) of 39%—a pivotal factor reshaping the industry landscape.

III. Policy and Cost-Driven Factors
- Environmental Regulations: China’s “Dual Carbon” goals and the New Pollutants Governance Action are accelerating the elimination of outdated production capacity. In 2026, the industry’s CR5 (combined market share of the top five enterprises) exceeded 65%. Vertically integrated enterprises—those owning fluorite mines and hydrofluoric acid production lines—maintain gross margins above 25%, markedly higher than non-integrated peers.
- Raw Material Costs: Upstream fluorite and hydrofluoric acid prices exhibit rigid upward trends due to resource scarcity and internalization of environmental compliance costs. In 2026, the average price of hydrofluoric acid increased by 12% year-on-year, raising 1,3-difluorobenzene production costs by approximately 8–10%. Leading firms partially offset cost pressures via long-term supply agreements, price-locking mechanisms, and process optimization—e.g., catalytic fluorination replacing direct fluorination.

IV. Competitive Landscape and Key Enterprise Developments
- Market Concentration: The global 1,3-difluorobenzene market features an “oligopolistic competition” structure. Zhejiang Xiehe New Materials (China), Daikin Industries (Japan), and Arkema (USA) collectively command over 60% of global market share. Domestic players are gradually eroding multinational competitors’ market positions through technological breakthroughs—such as elevating electronic-grade product purity to 99.99%—and cost advantages.
- Corporate Strategies:
- Capacity Expansion: Xiehe New Materials plans to commission a new 50,000-metric-ton-per-year production line in Zhangjiagang, Jiangsu Province, by 2027, strategically aligned to serve OLED panel manufacturers in the Yangtze River Delta region.
- Technology Upgrade: Jinhongtai Chemical has partnered with the Institute of Process Engineering, Chinese Academy of Sciences, to develop a microwave-assisted fluorination process—reducing reaction time by 40% and energy consumption by 25%. Pilot-scale validation is scheduled for completion in Q3 2026.
- Vertical Integration: Several enterprises are extending upstream into fluorite mining and downstream into fluoropolymer modification, establishing fully integrated value chains spanning “mineral resources → fluorinated compounds → end-use materials.”

V. Future Outlook and Trends
- Price Forecast: In the short term (Q3 2026), prices may remain stable or rise modestly, supported by peak-season demand from pharmaceutical intermediates, with an anticipated range of RMB 34,500–37,000 per metric ton. Over the medium-to-long term (2027–2030), the price center is expected to shift upward to above RMB 40,000 per metric ton, driven by explosive demand from new-energy applications—though periodic price corrections may occur amid accelerated capacity deployment.
- Technological Directions: Green chemistry (e.g., atom-economical reactions, solvent recovery), intelligent manufacturing (e.g., AI-driven reaction parameter optimization, digital twin factories), and high-end product development (e.g., electronic-grade and semiconductor-grade specifications) will define the core technical evolution pathways.
- Market Opportunities:
- Regional Markets: The Asia-Pacific region—particularly China and India—is witnessing rapid growth in pharmaceuticals and electronics industries, resulting in demand growth rates outpacing the global average; the CAGR for 2026–2030 is forecast at 8.2%.
- Niche Applications: Emerging use cases—including fluorinated solvents for solid-state battery electrolytes and low-dielectric-constant fluorinated polymers for 5G communications—will generate incremental markets worth hundreds of millions of RMB.
- Risk Warnings: Geopolitical conflicts may disrupt raw material supply chains; increasingly stringent environmental regulations could raise compliance costs; and disruptive technological shifts—such as biocatalytic fluorination—may fundamentally alter the competitive landscape.